Literature DB >> 35809144

Psychometric Evaluation and Predictive Validity of an Adapted Adherence Self-Efficacy Scale for PrEP.

Sarit A Golub1,2, Lila Starbuck3, Rachel Fikslin3,4, Kristi E Gamarel5.   

Abstract

Adherence to and sustainment of HIV pre-exposure prophylaxis (PrEP) are critical to its effectiveness. Adherence self-efficacy, i.e., confidence in one's ability to adhere to a particular medication, is a key psychological determinant of health behavior that strongly predicts HIV treatment adherence but has been understudied in PrEP research. This paper describes the psychometric evaluation and validation of the PrEP Adherence Self-Efficacy Scale (PrEP-ASES), adapted from the previously validated HIV Treatment Adherence Self-Efficacy Scale (HIV-ASES). Data are drawn from two studies conducted at a community health center, one focused on gay and bisexual cisgender men and the other on transgender women. Factor analyses support a one-factor score (eigenvalue = 6.78) that explained 75.3% of the variance, with good test-retest reliability (rs > 0.40). In both studies, higher PrEP-ASES scores were associated with PrEP uptake, adherence, and sustainment. Findings support the utility of the PrEP-ASES in research and suggest the importance of addressing self-efficacy in PrEP programs and services.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Adherence; HIV; Persistence; Pre-exposure prophylaxis (PrEP); Self-efficacy

Year:  2022        PMID: 35809144     DOI: 10.1007/s10461-022-03758-7

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  39 in total

1.  The role of self-efficacy in HIV treatment adherence: validation of the HIV Treatment Adherence Self-Efficacy Scale (HIV-ASES).

Authors:  Mallory O Johnson; Torsten B Neilands; Samantha E Dilworth; Stephen F Morin; Robert H Remien; Margaret A Chesney
Journal:  J Behav Med       Date:  2007-06-23

2.  Ending the HIV Epidemic: A Plan for the United States.

Authors:  Anthony S Fauci; Robert R Redfield; George Sigounas; Michael D Weahkee; Brett P Giroir
Journal:  JAMA       Date:  2019-03-05       Impact factor: 56.272

Review 3.  Female and younger subjects have lower adherence in PrEP trials: a meta-analysis with implications for the uptake of PrEP service to prevent HIV.

Authors:  Ke Yun; Jun-Jie Xu; Jing Zhang; Jia-Ming Li; Qing-Hai Hu; Zhen-Xing Chu; Yong-Jun Jiang; Wen-Qing Geng; Hong Shang; Ning Wang
Journal:  Sex Transm Infect       Date:  2017-07-29       Impact factor: 3.519

4.  Preexposure Prophylaxis for HIV Prevention in a Large Integrated Health Care System: Adherence, Renal Safety, and Discontinuation.

Authors:  Julia L Marcus; Leo B Hurley; Charles Bradley Hare; Dong Phuong Nguyen; Tony Phengrasamy; Michael J Silverberg; Juliet E Stoltey; Jonathan E Volk
Journal:  J Acquir Immune Defic Syndr       Date:  2016-12-15       Impact factor: 3.731

Review 5.  Epidemiology of HIV in the USA: epidemic burden, inequities, contexts, and responses.

Authors:  Patrick S Sullivan; Anna Satcher Johnson; Elizabeth S Pembleton; Rob Stephenson; Amy C Justice; Keri N Althoff; Heather Bradley; Amanda D Castel; Alexandra M Oster; Eli S Rosenberg; Kenneth H Mayer; Chris Beyrer
Journal:  Lancet       Date:  2021-02-19       Impact factor: 79.321

Review 6.  Adherence to Pre-Exposure Prophylaxis in Adolescents and Young Adults: A Systematic Review and Meta-Analysis.

Authors:  Bianca A Allison; Laura Widman; J L Stewart; Reina Evans; Martha Perry
Journal:  J Adolesc Health       Date:  2021-05-29       Impact factor: 5.012

Review 7.  Behavioral and social interventions to promote optimal HIV prevention and care continua outcomes in the United States.

Authors:  Kristi E Gamarel; Wesley M King; Don Operario
Journal:  Curr Opin HIV AIDS       Date:  2022-03-01       Impact factor: 4.061

8.  Adherence to antiretroviral prophylaxis for HIV prevention: a substudy cohort within a clinical trial of serodiscordant couples in East Africa.

Authors:  Jessica E Haberer; Jared M Baeten; James Campbell; Jonathan Wangisi; Elly Katabira; Allan Ronald; Elioda Tumwesigye; Christina Psaros; Steven A Safren; Norma C Ware; Katherine K Thomas; Deborah Donnell; Meighan Krows; Lara Kidoguchi; Connie Celum; David R Bangsberg
Journal:  PLoS Med       Date:  2013-09-10       Impact factor: 11.069

9.  Characterization of HIV Preexposure Prophylaxis Use Behaviors and HIV Incidence Among US Adults in an Integrated Health Care System.

Authors:  J Carlo Hojilla; Leo B Hurley; Julia L Marcus; Michael J Silverberg; Jacek Skarbinski; Derek D Satre; Jonathan E Volk
Journal:  JAMA Netw Open       Date:  2021-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.